InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Browse the detailed record of transactions filed by Anevski Peter, Chief Executive Officer. Insider active across 1 companies, notably Progyny, Inc.. In total, 36 reports have been published. Total volume traded: €16.9m. The latest transaction was filed on 11 May 2022 — Don. Regulator: SEC (Form 4). The full history is free.
Declarations36 total
0111,921 shares0
Common Stock
SEC:0001415889-22-007058:0·
€795,27120,200 shares@ €39.36980.036% mcap4.7% of flow
Common Stock
SEC:0001179110-22-002067:0·
€176,8304,606 shares@ €38.39120.0080% mcap1.0% of flow
Common Stock
SEC:0001104659-22-030782:0·
€4m125,931 shares@ €34.96090.20% mcap25.8% of flow
Common Stock
SEC:0001179110-22-001971:0·
0128,135 shares0
Common Stock
SEC:0001179110-22-001966:0·
€643,16217,569 shares@ €36.60780.029% mcap3.8% of flow
Common Stock
SEC:0001179110-22-001412:0·
€643,16217,569 shares@ €36.60780.029% mcap11.0% of flow
Common Stock
SEC:0001179110-22-001412·
€22,075600 shares@ €36.7920.0010% mcap0.1% of flow
Common Stock
SEC:0001179110-22-001298:0·
084,000 shares0
Common Stock
SEC:0001179110-22-000280·
084,000 shares0
Common Stock
SEC:0001179110-22-000280:0·
0250,000 shares0
Common Stock
SEC:0001179110-22-000020·
0250,000 shares0
Common Stock
SEC:0001179110-22-000020:0·
€9,74912,379 shares@ €0.78750.0004% mcap0.2% of flow
Common Stock
SEC:0001179110-21-009303·
€9,74912,379 shares@ €0.78750.0004% mcap0.1% of flow
Common Stock
SEC:0001179110-21-009303:0·
€21,62127,500 shares@ €0.78620.0010% mcap0.4% of flow
Common Stock
SEC:0001179110-21-009233·
€21,62127,500 shares@ €0.78620.0010% mcap0.1% of flow
Common Stock
SEC:0001179110-21-009233:0·
€6,8248,700 shares@ €0.78440.0003% mcap0.1% of flow
Common Stock
SEC:0001179110-21-009044·
€6,8248,700 shares@ €0.78440.0003% mcap0.0% of flow
Common Stock
SEC:0001179110-21-009044:0·
€42,78955,000 shares@ €0.7780.0019% mcap0.7% of flow
Common Stock
SEC:0001179110-21-008997·
€42,78955,000 shares@ €0.7780.0019% mcap0.3% of flow
Common Stock
SEC:0001179110-21-008997:0·
€3m58,521 shares@ €43.90880.12% mcap44.1% of flow
Common Stock
SEC:0001179110-21-008460·
€3m58,521 shares@ €43.90880.12% mcap15.1% of flow
Common Stock
SEC:0001179110-21-008460:0·
084,000 shares0
Common Stock
SEC:0001179110-21-007043·
084,000 shares0
Common Stock
SEC:0001179110-21-007043:0·
€122,9692,300 shares@ €53.4650.0056% mcap2.1% of flow
Common Stock
SEC:0001179110-21-006949·
25 of 36 declarations
About Anevski Peter
Peter Anevski is the Chief Executive Officer of Progyny, Inc., a publicly traded company listed on Nasdaq that focuses on fertility, family-building, and women’s health benefits. He also serves on the company’s board of directors. Company disclosures indicate that he has served as CEO since January 2022, following earlier leadership roles as Chief Operating Officer from January 2017 through December 2021, President from June 2019 through December 2021, and Chief Financial Officer from January 2017 through September 2020. That progression suggests a broad internal command of finance, operations, and corporate strategy. ([investors.progyny.com](https://investors.progyny.com/static-files/ef9ddcbd-3bc8-4e92-9bb5-ec0b7b4c09d8)) Before joining Progyny, Anevski served as Executive Vice President and Chief Financial Officer of WebMD from May 2013 to September 2016. Prior to that, he held senior finance and operating roles at WebMD and predecessor businesses for roughly 14 years, giving him long experience in healthcare-related media, digital health, and consumer-focused services. Progyny describes him as having decades of experience building and scaling operations at leading healthcare and technology companies. He earned a B.A. in Accounting from Montclair State University. ([investors.progyny.com](https://investors.progyny.com/static-files/ef9ddcbd-3bc8-4e92-9bb5-ec0b7b4c09d8)) At Progyny, his leadership has been associated with the company’s broader expansion and product development strategy. The company says that under his leadership it has expanded its footprint to support millions of lives across the U.S. and globally, while introducing additional solutions across fertility, maternal health, parenting, menopause, and midlife care. His approach is described as centered on an integrated, data-driven model designed to improve outcomes, enhance the member experience, and lower employer costs. In practical terms, this positions Anevski as a finance- and operations-oriented executive who has moved into a top strategic role after years of hands-on experience inside the same organization. ([investors.progyny.com](https://investors.progyny.com/management/peter-anevski/))
